Incyte (INCY) Misses Q2 EPS by 3c, Sales Beat; Raises FY17 Jakafi Revenue Outlook
Go back to Incyte (INCY) Misses Q2 EPS by 3c, Sales Beat; Raises FY17 Jakafi Revenue Outlook| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 108.46 +4.06 (3.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.40 | 52 Week High | $118.49 | |||
| Open | $105.53 | 52 Week Low | $55.00 | |||
| Day High | $109.10 | P/E | N/A | |||
| Day Low | $104.49 | EPS | $-0.56 | |||
| Volume | 1,963,899 | |||||
